Eton Pharmaceuticals (ETON) Total Debt (2019 - 2026)

Eton Pharmaceuticals has disclosed Total Debt across 8 years of filings, most recently posting $27.9 million for Q2 2026.

• In Q2 2026, Total Debt fell 7.54% year-over-year to $27.9 million; the TTM figure through Jun 2026 stood at $27.9 million (down 7.54% YoY), while the FY2025 annual figure was $30.6 million, up 2.51% from the prior year.
• Total Debt came in at $27.9 million for Q2 2026 at Eton Pharmaceuticals, down from $30.6 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $30.6 million in Q4 2025 to a low of $4.1 million in Q3 2024.
• Average Total Debt over 5 years is $14.2 million, with a median of $6.4 million recorded in 2022.
• Year-over-year, Total Debt decreased 28.1% in 2024 and surged 636.17% in 2025.
• Over 5 years, Total Debt stood at $6.4 million in 2022, then fell by 16.16% to $5.4 million in 2023, then surged by 454.11% to $29.8 million in 2024, then advanced by 2.51% to $30.6 million in 2025, then retreated by 8.69% to $27.9 million in 2026.
• Per Business Quant data, the three most recent Total Debt figures were $27.9 million in Q2 2026, $30.6 million in Q4 2025, and $30.4 million in Q3 2025.